Matt Gethers

From OpenWetWare

Revision as of 20:14, 14 February 2009 by Mgethers (Talk | contribs)
Jump to: navigation, search

I'm currently a sophomore in course 20. When I'm behaving myself, I'm allowed to work in the Endy Lab at MIT. I have links to my UROP projects and 20.109 work directly below.


Contents

UROP Projects

Articles of General Interest

Articles to Read

Translation Demand

Mitochondrial Engineering

CRI Thailand

Matt's Stanford Freezer Stocks

OWW Syntax

Eloranta Ideas

20.109 Work

Class projects

20.310 Term Paper

20.310 Project

  1. Galkin O, Pan W, Filobelo L, Hirsch RE, Nagel RL, and Vekilov PG. . pmid:17449671. PubMed HubMed [Galkin]
  2. Carragher B, Bluemke DA, Gabriel B, Potel MJ, and Josephs R. . pmid:3351926. PubMed HubMed [Carragher]
  3. Bluemke DA, Carragher B, Potel MJ, and Josephs R. . pmid:3351927. PubMed HubMed [Carragher2]
  4. Carragher B, Bluemke DA, Becker M, McDade WA, Potel MJ, and Josephs R. . pmid:3351930. PubMed HubMed [Carragher3]
  5. Jones CW, Wang JC, Ferrone FA, Briehl RW, and Turner MS. . pmid:12638863. PubMed HubMed [Turner]
  6. Wang JC, Turner MS, Agarwal G, Kwong S, Josephs R, Ferrone FA, and Briehl RW. . pmid:11812133. PubMed HubMed [Wang]
All Medline abstracts: PubMed HubMed

Treatments exist for preventive and palliative treatment of sickle cell episodes, but no treatment has yet been developed to mitigate the effects of an attack once it has started. We need a way of dealing with Hbs fibers once they have polymerized. We feel we can develop a treatment for an ongoing attack by addressing the biomechanical basis of the pathology.

Personal tools